BDNF level is decreased in the nigrostriatal pathway of patients with PD, and attempts to upregulate BDNF level by gene modulation or direct delivery of BDNF to patients’ brain were unsatisfactory (Howells et al., 2000; Palasz et al., 2020). The gene discussed is BDNF; the disease is Parkinson disease.